You just read:

Jennerex Publishes Clinical Data in Journal, Nature, Demonstrating Intravenous Delivery of Multi-Mechanistic Cancer-Targeted Oncolytic Poxvirus JX-594 to Tumors

News provided by

Jennerex, Inc.

Aug 31, 2011, 01:00 ET